Table 2.
Studies comparing JCPyV DNA prevalence between cases and controls
| Reference | Positive cases/total cases (%) Type of Sample |
Positive controls/total controls (%) Type of Sample |
|---|---|---|
| [125] | 0/233 (0%) CRC tumor tissue |
1/233 (0.4%) Adjacent noncancerous tissue |
| [128] | 49/80 (61.3%) CRC tumor tissue |
6/20 (30.0%) Healthy tissue |
| 15/25 (60.0%) Adenoma tissue | ||
| [115] | 6/23 (26.1%) CRC tumor tissue |
0/20 (0%) Healthy tissue |
| 1/21 (4.8%) Adenoma tissue | ||
| [126] | 15/18 (8.3%) CRC tumor tissue |
13/16 (81.2%) Adjacent noncancerous tissue |
| [112] | 19/22 (86.4%) CRC tumor tissue |
0/22 (0.0%) Adjacent noncancerous tissue |
| [129] | 0/94 (0.0%) Adenoma tissue |
0/91 (0.0%) Healthy tissue |
| [124] | 56/137 (40.9%) CRC tumor tissue |
34/137 (24.8%) Adjacent noncancerous tissue |
| 11/80 (13.8%) Healthy tissue | ||
| [127] | 12/14 (85.7%) CRC tumor tissue |
40/100 (40.0%) Healthy tissue |
| 55/60 (91.7%) Adenoma tissue | ||
| [132] | 38/114 (33.3%) CRC glandular/stromal tissue |
2/20 (10%) Healthy glandular/stromal tissue |
| 6/40 (15.0%) Adenoma glandular/stromal tissue | ||
| [117] | 61/105 (58.1%) CRC tumor tissue |
13/89 (14.6%) Adjacent noncancerous tissue |